Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03971474
Brief Title: Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)

First Submitted : May 29, 2019
First Submitted that Met QC Criteria : May 30, 2019
First Posted : June 3, 2019

Last Update Submitted that Met QC Criteria : August 11, 2020
Last Update Posted : August 12, 2020